◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 0767

Zhong Ji Longevity Science Group Limited (0767) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-08-10

Zhong Ji Longevity Science Group Limited (0767) operates in the Diagnostics & Research industry and is headquartered in Kowloon Bay, Hong Kong with about 43 employees. Its market capitalization is roughly HKD 248 million. In the fiscal year ended 2025-12-31, 0767 reported HKD 162M in revenue and (HKD 17M) in net income.

Zhong Ji Longevity Science Group Limited, an investment holding company, engages in the money lending business in Hong Kong and Mainland China. It operates through Longevity Science Business; Money Lending and Financial Advisory Business; Securities and Other Investments; and Property Investment segments.

Interactive charts & full statements →

0767 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueHKD 162MHKD 166MHKD 65MHKD 90M
Gross ProfitHKD 26MHKD 57MHKD 56MHKD 84M
Operating Income (EBIT)(HKD 24M)(HKD 9M)(HKD 25M)HKD 12M
Net Income(HKD 17M)(HKD 35M)HKD 2M(HKD 1M)

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0767 Free Cash Flow History

0767 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsHKD 500MHKD 526MHKD 509MHKD 485M
Total LiabilitiesHKD 75MHKD 126MHKD 79MHKD 64M

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0767 viewer.

Other Companies in Diagnostics & Research

← 0765All “0-9” companies0769 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.